• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在感染持续时间不明的初治抗逆转录病毒治疗个体中进行HIV标准基因分型的临床效用。

Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.

作者信息

Smith Davey, Moini Niousha, Pesano Rick, Cachay Edward, Aiem Heidi, Lie Yolanda, Richman Douglas, Little Susan

机构信息

University of California San Diego, San Diego, CA 92103, USA.

出版信息

Clin Infect Dis. 2007 Feb 1;44(3):456-8. doi: 10.1086/510748. Epub 2006 Dec 28.

DOI:10.1086/510748
PMID:17205459
Abstract

In clinical settings, we have found a high rate of human immunodeficiency virus (HIV) drug resistance among antiretroviral-naive patients for whom the duration of infection was unknown. These high rates were most likely the result of both transmitted resistance and informal antiretroviral use, and they suggest that routine resistance testing among antiretroviral-naive patients would be a cost-effective clinical practice.

摘要

在临床环境中,我们发现对于感染持续时间未知的初治抗逆转录病毒治疗患者,人类免疫缺陷病毒(HIV)耐药率很高。这些高耐药率很可能是传播性耐药和非正规抗逆转录病毒药物使用共同导致的结果,这表明在初治抗逆转录病毒治疗患者中进行常规耐药检测将是一种具有成本效益的临床实践。

相似文献

1
Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.在感染持续时间不明的初治抗逆转录病毒治疗个体中进行HIV标准基因分型的临床效用。
Clin Infect Dis. 2007 Feb 1;44(3):456-8. doi: 10.1086/510748. Epub 2006 Dec 28.
2
Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.在泰国广泛使用抗逆转录病毒药物的初治和经治患者中的基因型耐药突变:对进一步流行病学监测的意义
Jpn J Infect Dis. 2007 Sep;60(5):284-9.
3
Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.初治囚犯中的抗逆转录病毒药物耐药性突变
Clin Infect Dis. 2002 Oct 1;35(7):883-6. doi: 10.1086/342697. Epub 2002 Sep 11.
4
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].[2001 - 2005年德国北莱茵 - 威斯特法伦州慢性HIV感染患者的原发性耐药流行病学]
Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. doi: 10.1055/s-2007-979365.
5
Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.实验室工具在格鲁吉亚常规临床护理中成功应用于检测艾滋病毒耐药性。
Georgian Med News. 2008 Dec(165):16-22.
6
Resistance and replication capacity assays: clinical utility and interpretation.耐药性与复制能力检测:临床应用与解读
Top HIV Med. 2004 May-Jun;12(2):52-6.
7
Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.喀麦隆一家常规诊所中抗逆转录病毒耐药性HIV感染水平较低,该诊所采用世界卫生组织(WHO)的公共卫生方法来监测抗逆转录病毒治疗以及二线治疗是否符合WHO的建议。
Clin Infect Dis. 2009 May 1;48(9):1318-22. doi: 10.1086/597779.
8
A physician's primer to antiretroviral drug resistance testing.抗逆转录病毒药物耐药性检测医师指南。
AIDS Read. 2000 Aug;10(8):469-73, 476-8.
9
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.意大利接受联合抗逆转录病毒治疗失败患者中HIV-1耐药性的演变及预测因素
Antivir Ther. 2009;14(3):359-69.
10
[Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].[智利近期感染人类免疫缺陷病毒(HIV)患者的原发性抗逆转录病毒耐药性检测]
Rev Med Chil. 2007 Nov;135(11):1406-13. Epub 2008 Jan 16.

引用本文的文献

1
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.喀麦隆西北部城乡地区的治疗前耐药性和 HIV-1 遗传多样性。
PLoS One. 2020 Jul 21;15(7):e0235958. doi: 10.1371/journal.pone.0235958. eCollection 2020.
2
Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil.巴西南部 HIV-1 传播耐药突变的中度流行率。
AIDS Res Ther. 2019 Feb 5;16(1):4. doi: 10.1186/s12981-019-0219-1.
3
Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.
1996 - 2013年加利福尼亚州圣地亚哥近期感染者中传播性艾滋病毒耐药性的流行情况
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):228-36. doi: 10.1097/QAI.0000000000000831.
4
Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).过去16年(1997 - 2012年)巴塞罗那急性或近期感染HIV-1患者的耐药性传播趋势及非B亚型流行情况
PLoS One. 2015 Jun 3;10(6):e0125837. doi: 10.1371/journal.pone.0125837. eCollection 2015.
5
Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.非B亚型HIV-1的耐药性:HIV-1逆转录酶抑制剂的影响
Viruses. 2014 Sep 24;6(9):3535-62. doi: 10.3390/v6093535.
6
Nevirapine inhibits the anti-HIV activity of CD8+ cells.奈韦拉平抑制 CD8+ 细胞的抗 HIV 活性。
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):184-8. doi: 10.1097/QAI.0b013e318289822d.
7
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance.建立暴露前预防干预措施和治疗方案之间的动态相互作用模型:预测 HIV 传播和耐药性。
Sci Rep. 2011;1:185. doi: 10.1038/srep00185. Epub 2011 Dec 7.
8
Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa.南非东北部一家自愿咨询检测中心新诊断出的未接受过抗逆转录病毒治疗人群中抗逆转录病毒药物耐药性突变和HIV-1亚型的流行情况。
J Health Popul Nutr. 2011 Aug;29(4):303-9. doi: 10.3329/jhpn.v29i4.8444.
9
Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.多米尼加共和国圣多明各初治的已确诊感染1型艾滋病毒患者中的传播性耐药情况以及拉丁美洲和加勒比地区文献综述
AIDS Res Hum Retroviruses. 2012 Jul;28(7):667-74. doi: 10.1089/aid.2010.0355. Epub 2011 Sep 23.
10
HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.HIV、传播耐药性和暴露前预防的悖论。
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12381-6. doi: 10.1073/pnas.1006061107. Epub 2010 Jun 28.